These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 33973403)

  • 1. Cardiovascular Safety of Hydroxychloroquine in US Veterans With Rheumatoid Arthritis.
    Faselis C; Zeng-Treitler Q; Cheng Y; Kerr GS; Nashel DJ; Liappis AP; Weintrob AC; Karasik PE; Arundel C; Boehm D; Heimall MS; Connell LB; Taub DD; Shao Y; Redd DF; Sheriff HM; Zhang S; Fletcher RD; Fonarow GC; Moore HJ; Ahmed A
    Arthritis Rheumatol; 2021 Sep; 73(9):1589-1600. PubMed ID: 33973403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydroxychloroquine and Risk of Long QT Syndrome in Rheumatoid Arthritis: A Veterans Cohort Study With Nineteen-Year Follow-up.
    Quiñones ME; Joseph JK; Dowell S; Moore HJ; Karasik PE; Fonarow GC; Fletcher RD; Cheng Y; Zeng-Treitler Q; Arundel C; Liappis AP; Sheriff HM; Zhang S; Taub DD; Heimall MS; Faselis C; Kerr GS; Ahmed A
    Arthritis Care Res (Hoboken); 2023 Jul; 75(7):1571-1579. PubMed ID: 36039941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydroxychloroquine Does Not Increase the Risk of Cardiac Arrhythmia in Common Rheumatic Diseases: A Nationwide Population-Based Cohort Study.
    Lo CH; Wei JC; Wang YH; Tsai CF; Chan KC; Li LC; Lo TH; Su CH
    Front Immunol; 2021; 12():631869. PubMed ID: 33868251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic hydroxychloroquine use associated with QT prolongation and refractory ventricular arrhythmia.
    Chen CY; Wang FL; Lin CC
    Clin Toxicol (Phila); 2006; 44(2):173-5. PubMed ID: 16615675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of Arrhythmia Among New Users of Hydroxychloroquine in Rheumatoid Arthritis and Systemic Lupus Erythematosus: A Population-Based Study.
    Hoque MR; Lu L; Daftarian N; Esdaile JM; Xie H; Aviña-Zubieta JA
    Arthritis Rheumatol; 2023 Mar; 75(3):475-484. PubMed ID: 36054570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-World Outcomes Associated With Methotrexate, Sulfasalazine, and Hydroxychloroquine Triple Therapy Versus Tumor Necrosis Factor Inhibitor/Methotrexate Combination Therapy in Patients With Rheumatoid Arthritis.
    Curtis JR; Palmer JL; Reed GW; Greenberg J; Pappas DA; Harrold LR; Kremer JM
    Arthritis Care Res (Hoboken); 2021 Aug; 73(8):1114-1124. PubMed ID: 32374918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydroxychloroquine use is associated with reduced mortality risk in older adults with rheumatoid arthritis.
    Iyer P; Gao Y; Jalal D; Girotra S; Singh N; Vaughan-Sarrazin M
    Clin Rheumatol; 2024 Jan; 43(1):87-94. PubMed ID: 37498463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydroxychloroquine may be associated with reduced risk of coronary artery diseases in patients with rheumatoid arthritis: A nationwide population-based cohort study.
    Hung YM; Wang YH; Lin L; Wang PYP; Chiou JY; Wei JC
    Int J Clin Pract; 2018 May; 72(5):e13095. PubMed ID: 29691971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of depression, suicide and psychosis with hydroxychloroquine treatment for rheumatoid arthritis: a multinational network cohort study.
    Lane JCE; Weaver J; Kostka K; Duarte-Salles T; Abrahao MTF; Alghoul H; Alser O; Alshammari TM; Areia C; Biedermann P; Banda JM; Burn E; Casajust P; Fister K; Hardin J; Hester L; Hripcsak G; Kaas-Hansen BS; Khosla S; Kolovos S; Lynch KE; Makadia R; Mehta PP; Morales DR; Morgan-Stewart H; Mosseveld M; Newby D; Nyberg F; Ostropolets A; Woong Park R; Prats-Uribe A; Rao GA; Reich C; Rijnbeek P; Sena AG; Shoaibi A; Spotnitz M; Subbian V; Suchard MA; Vizcaya D; Wen H; Wilde M; Xie J; You SC; Zhang L; Lovestone S; Ryan P; Prieto-Alhambra D;
    Rheumatology (Oxford); 2021 Jul; 60(7):3222-3234. PubMed ID: 33367863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydroxychloroquine/azithromycin treatment, QT interval and ventricular arrhythmias in hospitalised patients with COVID-19.
    Özdemir İH; Özlek B; Özen MB; Gündüz R; Çetin N; Bilge AR
    Int J Clin Pract; 2021 Feb; 75(2):e13896. PubMed ID: 33280207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of hydroxychloroquine treatment on QT interval.
    Hooks M; Bart B; Vardeny O; Westanmo A; Adabag S
    Heart Rhythm; 2020 Nov; 17(11):1930-1935. PubMed ID: 32610165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydroxychloroquine and risk of osteoporosis in patients with rheumatoid arthritis: A population-based retrospective study of 6408 patients.
    Dong C; Chen BS; Wu CH; Chiu YM; Liao PL; Perng WT
    Int J Rheum Dis; 2024 Aug; 27(8):e15286. PubMed ID: 39154356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations of hydroxychloroquine use with lipid profiles in rheumatoid arthritis: pharmacologic implications.
    Kerr G; Aujero M; Richards J; Sayles H; Davis L; Cannon G; Caplan L; Michaud K; Mikuls T
    Arthritis Care Res (Hoboken); 2014 Nov; 66(11):1619-26. PubMed ID: 24692402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety of Biologic and Nonbiologic Disease-modifying Antirheumatic Drug Therapy in Veterans with Rheumatoid Arthritis and Hepatitis C Virus Infection.
    Burton MJ; Curtis JR; Yang S; Chen L; Singh JA; Mikuls TR; Winthrop KL; Baddley JW
    J Rheumatol; 2017 May; 44(5):565-570. PubMed ID: 28250142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydroxychloroquine and Cardiovascular Events in Patients with Rheumatoid Arthritis.
    Cordova Sanchez A; Khokhar F; Olonoff DA; Carhart RL
    Cardiovasc Drugs Ther; 2024 Apr; 38(2):297-304. PubMed ID: 36197529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistence With Conventional Triple Therapy Versus a Tumor Necrosis Factor Inhibitor and Methotrexate in US Veterans With Rheumatoid Arthritis.
    Sauer BC; Teng CC; Tang D; Leng J; Curtis JR; Mikuls TR; Harrison DJ; Cannon GW
    Arthritis Care Res (Hoboken); 2017 Mar; 69(3):313-322. PubMed ID: 27273801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An observational, retrospective, comprehensive pharmacovigilance analysis of hydroxychloroquine-associated cardiovascular adverse events in patients with and without COVID-19.
    Luo M; Wu B; Li Y; Wu F
    Int J Clin Pharm; 2022 Oct; 44(5):1179-1187. PubMed ID: 35857159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between disease-modifying antirheumatic drugs and diabetes risk in patients with rheumatoid arthritis and psoriasis.
    Solomon DH; Massarotti E; Garg R; Liu J; Canning C; Schneeweiss S
    JAMA; 2011 Jun; 305(24):2525-31. PubMed ID: 21693740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and immunological effects of hydroxychloroquine in patients with active rheumatoid arthritis despite antirheumatic treatment.
    Takei H; Takanashi S; Otomo K; Hanaoka H; Kikuchi J; Yamaoka K; Yoshimoto K; Abe T; Takeuchi T; Kaneko Y
    Mod Rheumatol; 2023 Dec; 34(1):50-59. PubMed ID: 36484525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic and cardiovascular benefits of hydroxychloroquine in patients with rheumatoid arthritis: a systematic review and meta-analysis.
    Rempenault C; Combe B; Barnetche T; Gaujoux-Viala C; Lukas C; Morel J; Hua C
    Ann Rheum Dis; 2018 Jan; 77(1):98-103. PubMed ID: 28970215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.